0 likes | 13 Views
Discover the intricacies of Gilteritinib's mechanism at impomed healthcare. Unveil the scientific essence behind this groundbreaking pharmaceutical, exploring how it precisely targets and inhibits specific cellular pathways. Our comprehensive analysis delves into the molecular interactions, providing insights into its efficacy and potential therapeutic benefits. Join us on a journey through the cutting-edge research that defines Gilteritinib's role in advancing healthcare, as we strive to empower our audience with knowledge and foster a deeper understanding of innovative medical solutions. Wel
E N D
GILTERITINIB Home | Cancer | Blood Cancer | GILTERITINIB GILTERITINIB Tablets Description Composition Dosage Indications XOSPATA (gilteritinib) is a tyrosine kinase inhibitor. XOSPATA (gilteritinib) is provided as a tablet for oral administration. Each tablet contains 40 mg of gilteritinib active ingredient as free base (corresponding to 44.2 mg gilteritinib fumarate). The inactive ingredients are mannitol, hydroxypropyl cellulose, low-substituted hydroxypropyl cellulose, magnesium stearate, hypromellose, talc, polyethylene glycol, titanium dioxide and ferric oxide. Copyright © 2024 ImpoMed Convert web pages and HTML files to PDF in your applications with the Pdfcrowd HTML to PDF API Printed with Pdfcrowd.com